Henry Schein, Inc. (HSIC) Scheduled to Post Earnings on Tuesday
Henry Schein, Inc. (NASDAQ:HSIC) will release its earnings data before the market opens on Tuesday, October 31st. Analysts expect Henry Schein to post earnings of $0.90 per share for the quarter. Henry Schein has set its FY17 guidance at $7.17-7.30 EPS.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.82 earnings per share. On average, analysts expect Henry Schein to post $3.64 EPS for the current fiscal year and $4.01 EPS for the next fiscal year.
Henry Schein, Inc. (NASDAQ HSIC) traded up 0.23% during mid-day trading on Tuesday, reaching $83.04. 495,524 shares of the company’s stock traded hands. Henry Schein, Inc. has a 12-month low of $73.11 and a 12-month high of $93.50. The stock has a 50-day moving average price of $82.35 and a 200-day moving average price of $87.30. The stock has a market capitalization of $13.13 billion, a PE ratio of 24.27 and a beta of 1.09.
Henry Schein declared that its board has approved a stock buyback plan on Monday, September 18th that allows the company to buyback $400.00 million in shares. This buyback authorization allows the company to reacquire up to 6.3% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.
In related news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.19% of the company’s stock.
HSIC has been the subject of several research reports. UBS AG reiterated a “buy” rating on shares of Henry Schein in a research report on Friday, September 15th. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 target price for the company in a report on Monday, August 7th. Robert W. Baird set a $95.00 target price on shares of Henry Schein and gave the stock a “buy” rating in a report on Thursday, October 19th. Morgan Stanley began coverage on shares of Henry Schein in a report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 target price for the company. Finally, Stifel Nicolaus restated a “hold” rating and issued a $89.00 target price on shares of Henry Schein in a report on Thursday, October 19th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $92.89.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.